11.44
Avantor Inc stock is traded at $11.44, with a volume of 12.28M.
It is up +0.79% in the last 24 hours and up +18.06% over the past month.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
See More
Previous Close:
$11.35
Open:
$11.39
24h Volume:
12.28M
Relative Volume:
1.26
Market Cap:
$7.81B
Revenue:
$6.55B
Net Income/Loss:
$-551.40M
P/E Ratio:
-14.15
EPS:
-0.8082
Net Cash Flow:
$438.90M
1W Performance:
+3.34%
1M Performance:
+18.06%
6M Performance:
-3.05%
1Y Performance:
-18.34%
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AVTR
Avantor Inc
|
11.44 | 7.81B | 6.55B | -551.40M | 438.90M | -0.8082 |
|
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-17-25 | Downgrade | Jefferies | Hold → Underperform |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-04-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-01-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-29-25 | Downgrade | Goldman | Buy → Neutral |
| Apr-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Apr-28-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
| Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-30-21 | Resumed | Raymond James | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-04-21 | Initiated | Goldman | Buy |
| Apr-29-21 | Upgrade | Stifel | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Aug-02-19 | Initiated | Cleveland Research | Neutral |
| Jun-14-19 | Initiated | Janney | Buy |
| Jun-12-19 | Initiated | Raymond James | Outperform |
| Jun-11-19 | Initiated | Goldman | Buy |
| Jun-11-19 | Initiated | Guggenheim | Buy |
| Jun-11-19 | Initiated | JP Morgan | Overweight |
| Jun-11-19 | Initiated | Jefferies | Buy |
| Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-19 | Initiated | Robert W. Baird | Outperform |
| Jun-11-19 | Initiated | SunTrust | Buy |
| Jun-11-19 | Initiated | UBS | Buy |
| Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
Avantor, Inc. Revenue Breakdown – BMV:AVTR - TradingView
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Avantor, Inc. (AVTR) Stock forecasts - Yahoo Finance Singapore
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
Avantor Inc (AVTR) Stock Up 3.6% and Still Undervalued -- GF Sco - GuruFocus
Avantor stock holds steady as investors weigh recent earnings and life sciences demand - AD HOC NEWS
AVTR: Avantor Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Shareholders to Reach Out - ACCESS Newswire
Avantor, Inc. (AVTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Avantor stock trades steady as investors weigh recent earnings and life sciences demand - AD HOC NEWS
Avantor Inc (AVTR) Shares Fall 3.7% -- What GF Score of 61 Tells Investors - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-07-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation | NYSE:AVTR | Press Release - Stockhouse
Avantor, Inc. Announces Amendment No. 15 to Credit Agreement, Extending Euro Term Loan Maturity to 2032 - Minichart
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avantor Lowers Borrowing Costs by Refinancing €374.2 Million Euro-Denominated Term Loans with Credit Agreement Amendment - Kalkine Media
Avantor Unit Enters Amendment No. 15 To Credit Agreement On July 14, 2026SEC Filing - TradingView
Avantor Refinances €374.2 Million Euro Term Loans at EURIBO + 2.00% Under Credit Amendment - TradingView
Avantor (NYSE: AVTR) refinances €374,208,296.62 in Euro term loans - Stock Titan
Trading Systems Reacting to (AVTR) Volatility - Stock Traders Daily
Will Avantor (AVTR) beat estimates again in its next earnings report? - MSN
Is Avantor (AVTR) Quietly Redefining Its Healthcare Role With NuSil’s HIV-Prevention Partnership? - simplywall.st
Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Avantor Jumps 6.2% Amid Sector-Wide Rally - AlphaStreet
Avantor Inc (AVTR) Stock Up 6.9% and Still Undervalued -- GF Sco - GuruFocus
Avantor expands partnership for HIV prevention ring development By Investing.com - Investing.com Nigeria
Avantor expands partnership for HIV prevention ring development - Investing.com
Avantor expands collaboration to develop a thre... - Pluang
New HIV prevention ring could cut use from 12 rings to four - Stock Titan
Price to earnings forward of Avantor, Inc. – LSX:A2PJN6 - TradingView
Avantor, Inc. Stock 12‑Month Price Target Raised to $10.31, Implies 1% Downside - TradingView
BofA Securities Adjusts Avantor Price Target to $12 From $10 - Moomoo
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avantor (AVTR) Gains Traction Under New Management - Yahoo Finance
Avantor, Inc. Stock 12‑Month Price Target Raised to $10.19, Implies 2% Downside - TradingView
Enterprise value to EBITDA forward of Avantor, Inc. – LSX:A2PJN6 - TradingView
Investors in Avantor, Inc. (AVTR): Protect Your Rights – Contact Levi & Korsinsky Before December 29, 2025 - The National Law Review
Avantor stock reflects steady life sciences demand amid global biosciences expansion - ad-hoc-news.de
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Investors to Connect - ACCESS Newswire
Here's why you should hold Avantor stock in your portfolio for now - MSN
Avantor Inc (AVTR) Stock Up 7.7% and Still Undervalued -- GF Sco - GuruFocus
Avantor stock reflects life science demand amid diversified growth - ad-hoc-news.de
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now - TradingView
Avantor Price Target Raised to $11.00/Share From $9.00 by Citigroup - Moomoo
Avantor Is Maintained at Neutral by Citigroup - Moomoo
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Avantor Inc focuses on life sciences growth while investors monitor its Nasdaq listing - ad-hoc-news.de
Evercore Maintains Avantor(AVTR.US) With Hold Rating, Raises Target Price to $10.5 - Moomoo
Avantor Is Maintained at In-Line by Evercore ISI Group - Moomoo
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):